Mineralys Therapeutics, Inc.
MLYS
43 insider filings · Latest: Sep 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Apr 13 8:22 PM | Congleton Jon | Proposed Sale | 15,730 | $26.83 | $422.0K | — | View → |
| Apr 13, 2026 | Apr 13 8:18 PM | Rodman David Malcom | Proposed Sale | 14,058 | $26.54 | $373.1K | — | View → |
| Apr 9, 2026 | Apr 9 8:24 PM | Rodman David Malcom | Proposed Sale | 2,170 | $27.38 | $59.4K | — | View → |
| Mar 31, 2026 | Apr 2 10:54 PM | Jon CongletonDirector, Chief Executive Officer | Sale | 75,000 | $26.27 | $2.0M | 705,051(D) | View → |
| Mar 31, 2026 | Apr 2 10:53 PM | Daphne KarydasDirector | Sale | 3,000 | $25.00 | $75.0K | 6,200(D) | View → |
| Mar 31, 2026 | Mar 31 8:18 PM | Karydas Daphne | Proposed Sale | 3,000 | $25.00 | $75.0K | — | View → |
| Mar 31, 2026 | Mar 31 8:15 PM | Congleton Jon | Proposed Sale | 75,000 | $26.27 | $2.0M | — | View → |
| Mar 30, 2026 | Mar 31 8:15 PM | RA CAPITAL MANAGEMENT, L.P.Director | Purchase | 58,300 | $24.16 | $1.4M | 5,825,521(I) | View → |
| Mar 27, 2026 | Mar 31 8:15 PM | RA CAPITAL MANAGEMENT, L.P.Director | Purchase | 310,700 | $23.67 | $7.4M | 5,767,221(I) | View → |
| Mar 17, 2026 | Mar 17 9:04 PM | Rodman David Malcom | Proposed Sale | 417 | $25.65 | $10.7K | — | View → |
| Mar 17, 2026 | Mar 17 8:51 PM | David Malcom RodmanChief Medical Officer | Sale | 417 | $25.65 | $10.7K | 76,140(D) | View → |
| Mar 13, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Sale | 14,058 | $26.26 | $369.2K | 76,140(D) | View → |
| Mar 12, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $27.37 | $173.7K | 82,489(D) | View → |
| Mar 13, 2026 | Mar 13 8:50 PM | Rodman David Malcom | Proposed Sale | 14,058 | $26.26 | $369.2K | — | View → |
| Mar 12, 2026 | Mar 12 8:13 PM | Rodman David Malcom | Proposed Sale | 6,348 | $27.37 | $173.7K | — | View → |
| Mar 9, 2026 | Mar 10 9:48 PM | David Malcom RodmanChief Medical Officer | Sale | 2,171 | $26.84 | $58.3K | 82,489(D) | View → |
| Mar 9, 2026 | Mar 9 9:15 PM | Rodman David Malcom | Proposed Sale | 2,171 | $26.84 | $58.3K | — | View → |
| Feb 17, 2026 | Feb 17 11:56 PM | David Malcom RodmanChief Medical Officer | Sale | 417 | $27.59 | $11.5K | 44,089(D) | View → |
| Feb 17, 2026 | Feb 17 9:05 PM | Rodman David Malcom | Proposed Sale | 417 | $27.59 | $11.5K | — | View → |
| Feb 13, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Sale | 14,055 | $27.44 | $385.7K | 44,089(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,707 | $14.25 | 100,001(D) | View → |
| Feb 12, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,349 | $1.08 | 31,743(D) | View → |
| Feb 9, 2026 | Feb 11 11:58 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 26,047(D) | View → |
| Jan 20, 2026 | Jan 21 1:33 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 416 | $15.44 | 5,834(D) | View → |
← Previous
Page 3 of 3